ArticleTargeted oncology2018
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP).
Alejandro Ruiz-Patiño et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it